Galectin Therapeutics (GALT) Intangibles (2010 - 2016)
Galectin Therapeutics (GALT) recorded quarterly Intangibles of $78000.0 in Q4 2016, up 2500.0% quarter-over-quarter from $3000.0 in Q3 2016, and up 875.0% on a YoY basis from $8000.0 in Q1 2016.
Galectin Therapeutics (GALT) Intangibles (2010 - 2016) Analysis & Trends
Galectin Therapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $78000.0 for Q4 2016.
- In Q4 2016, Intangibles rose 875.0% year-over-year to $78000.0; the TTM figure through Dec 2016 stood at $78000.0 (up 875.0% YoY), while the FY2016 annual figure was $78000.0, up 875.0% from the prior year.
- Intangibles was $78000.0 for Q4 2016 at Galectin Therapeutics, up from $3000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $78000.0 in Q4 2012 to a low of $3000.0 in Q3 2016.
- Historically, Intangibles has averaged $27250.0 across 5 years, with a median of $20000.0 in 2014.
- The sharpest annual moves came in 2014 and 2016: Intangibles tumbled 80.77% in 2014, then surged 875.0% in 2016.
- A 5-year view of Intangibles shows it stood at $78000.0 in 2012, then changed by 0.0% to $78000.0 in 2013, then sank by 80.77% to $15000.0 in 2014, then plunged by 46.67% to $8000.0 in 2015, then soared by 875.0% to $78000.0 in 2016.
- The last three Intangibles figures came in at $78000.0 (Q4 2016), $3000.0 (Q3 2016), and $5000.0 (Q2 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Galectin Therapeutics | 185.83 Mn | 171.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 78,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Dec 31, 2015 | 8,000.00 |
| Sep 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 12,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Dec 31, 2014 | 15,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 78,000.00 |
| Sep 30, 2013 | 24,000.00 |
| Jun 30, 2013 | 26,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 78,000.00 |
| Sep 30, 2012 | 33,000.00 |
| Jun 30, 2012 | 34,000.00 |
| Mar 31, 2012 | 35,000.00 |